Full Alliance Group, Inc.'s (OTC:FAGI) Wholly Owned Subsidiary DynaMAXX Health, Inc. Launches PRiVIVE(TM) Topical Serum: A Revolutionary Solution for Cellular Rejuvenation and Dermal Health
Full Alliance Group, Inc.'s (OTC:FAGI) Wholly Owned Subsidiary DynaMAXX Health, Inc. Launches PRiVIVE(TM) Topical Serum: A Revolutionary Solution for Cellular Rejuvenation and Dermal Health
TAMPA, FL / ACCESSWIRE / June 18, 2024 / Full Alliance Group, Inc (OTC PINK:FAGI) is thrilled to announce the launch of PRiVIVE Topical Serum, a groundbreaking product designed to enhance cellular rejuvenation, collagen synthesis, dermal elasticity, and the relaxation of localized tissues. This unique and diverse formulation can be applied anywhere on the body, making it a versatile addition to anyone's skincare regimen.
全聯集團(OTC PINK:FAGI)非常高興地宣佈推出PRiVIVE局部補水精華液,這是一款開創性的產品,旨在增強細胞再生、膠原蛋白合成、真皮彈性和局部組織鬆弛度。這種獨特而多樣化的配方可以在身體的任何地方使用,使它成爲任何人護膚日常護理的多功能佳品。
Revolutionary Delivery Technology
革命性輸送技術
PRiVIVE is formulated with a proprietary and clinically demonstrated self-contained delivery technology. This advanced system dramatically enhances the permeation and cellular utilization of active compounds, ensuring maximum efficacy. PRiVIVE also allows for the addition of unique additives such as Platelet-Rich Plasma (PRP) or Exosomes, further maximizing their transport and utilization for one-of-a-kind aesthetic and therapeutic results.
PRiVIVE採用專有的並且得到臨床證實的自包含輸送技術進行調配。這種先進的系統極大地增強了活性化合物的滲透和細胞利用率,確保最大的功效。並且PRiVIVE產品還可以添加獨特的添加劑,如富含血小板的血漿(PRP)或外泌體,進一步提高它們的傳輸和利用效果,以達到獨一無二的美容和療效結果。
Transformative Additives for Enhanced Results
改變性添加劑以增強效果
One of the standout features of PRiVIVE is its compatibility with unique additives like Platelet-Rich Plasma (PRP) and Exosomes. PRP, derived from the patient's own blood, is rich in growth factors and has been shown to accelerate tissue repair and regeneration. When combined with PRiVIVE, the delivery technology ensures that PRP penetrates deeper into the skin, enhancing its rejuvenating effects and promoting faster healing and cellular turnover.
PRiVIVE的突出特點之一是其與血小板富集血漿(PRP)和外泌體等獨特添加劑的兼容性。PRP來源於患者自己的血液,富含生長因子,並且已被證明可以加速組織修復和再生。當與PRiVIVE結合時,傳遞技術確保PRP能夠更深層地滲透到皮膚內,增強其恢復效果,促進更快的癒合和細胞更新。
Similarly, Exosomes, which are extracellular vesicles known for their role in cell communication and regeneration, can be added to PRiVIVE. Exosomes are packed with proteins, lipids, and genetic material that can stimulate tissue repair and reduce inflammation. The advanced delivery system in PRiVIVE ensures these exosomes reach their target cells more effectively, leading to improved skin texture, elasticity, and overall appearance.
同樣地,PRiVIVE可以加入外泌體(exosomes)。外泌體是一種細胞間通訊和再生的細胞外囊泡,充滿了蛋白質、脂質和遺傳物質,可以促進組織修復和減少炎症。PRiVIVE的先進遞送系統可以更有效地將這些外泌體傳遞到目標細胞,從而改善肌膚紋理、彈性和外觀。
Key Ingredients and Their Benefits
主要成分及其優點
Centella Asiatica (Gotu Kola)
穿心蓮(Gotu Kola)
Promotes fibroblast proliferation
Increases collagen synthesis
Improves tensile strength of new skin
Supports proper healing following dermal injury
促進成纖維細胞增殖
促進膠原蛋白合成
提高新皮膚的拉伸強度
支持皮膚在真皮創傷後的適當癒合
PEA (Palmitoylethanolamide)
PEA(棕櫚酰酰胺)
Stimulates the nuclear receptor (PPAR-a)
Regulates immune response and mast cell stability
Involved in skin homeostasis, barrier protection, hydration, and regeneration
Contributes to proper inflammatory metabolism
刺激核激素受體(PPAR-a)
調節免疫反應和肥大細胞穩定性
參與皮膚穩態、屏障保護、水合和再生
有利於適當的炎症代謝
Oligopeptide-1 (Epidermal Growth Factor)
寡肽-1 (表皮生長因子)
Stimulates cell growth, healing, and differentiation
Boosts synthesis of collagen, elastin, and hyaluronic acid
促進細胞生長、癒合和分化
增加膠原蛋白、彈性蛋白和透明質酸的合成
Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Syn-Ake (二肽二氨基丁酰苄胺乙酸酯)
Synthetic tripeptide with molecular weight below 500 Da
分子量低於500 Da的合成三肽
Mimics Waglerin-1 functionality, a peptide found in the venom of the temple viper
Inhibits muscle contraction.
Reduces the appearance of deep wrinkles
模仿寺廟蝰蛇毒液中發現的Waglerin-1的功能的肽
抑制肌肉收縮。
減少深層皺紋的出現
Used as preventive, can delay progression of wrinkles associated with aging skin
Promotes relaxation via reduced muscle contraction, but does not affect facial expression
Potentially, local relaxation of muscles beneath the skin can improve local circulation
作爲預防用,可以延緩與老化皮膚相關的皺紋的發展
通過減少肌肉收縮促進放鬆,但不影響面部表情
潛在地,皮膚下面的肌肉局部放鬆可以改善局部循環
Exclusive Availability Through Medical Professionals
通過醫療專業人士專屬供應
PRiVIVE Topical Serum is available exclusively through medical professionals, ensuring that customers receive the highest quality product with expert guidance on its application and benefits. While DynaMAXX Health will offer PRiVIVE to other medical professionals, it will be primarily available through MAXX Health Clinics. These clinics are renowned for their commitment to providing advanced health solutions, making them the ideal partner for the launch of PRiVIVE.
PRiVIVE 保溼精華液僅通過醫療專業人士提供,確保客戶獲得高品質的產品,專業指導其應用和優點。然而,DynaMAXX Health 會向其他醫療專業人士提供PRiVIVE,主要通過MAXX Health Clinics提供。這些診所以提供先進的健康解決方案而著稱,是PRiVIVE推出的理想合作伙伴。
A Commitment to Excellence
承諾卓越
By offering PRiVIVE primarily through MAXX Health Clinics, Full Alliance Group reinforces its dedication to excellence and customer satisfaction. Patients can trust that they are receiving a product that has been rigorously tested and supported by clinical evidence, ensuring the best possible outcomes for their skin health and overall well-being. This selective distribution approach guarantees that PRiVIVE users receive the best care and guidance from trained medical professionals.
通過主要通過MAXX Health Clinics提供PRiVIVE,Full Alliance Group 強化了對卓越和客戶滿意度的承諾。患者可以信任他們收到已經通過嚴格測試和臨床證明支持的產品,確保他們的皮膚健康和整體健康獲得最佳結果。這種有選擇的分銷方式保證PRiVIVE用戶從訓練有素的醫療專業人員那裏獲得最好的護理和指導。
About Full Alliance Group, Inc.
關於全聯盟集團,Inc。
Full Alliance Group, Inc. is a holding company in the health and wellness sector.
Full Alliance Group, Inc. 是一個健康和健康行業的控股公司。
FAGI's wholly owned subsidiary, Bio Lab Naturals, Inc., founded in 2000, through its FDA-registered wholly owned subsidiary Pure Solutions, Inc., was built on the simple principles of using the highest quality ingredients, producing products with the greatest possible efficacy, and providing its partners with unsurpassed customer service all at a fair price. From day one, the Company has specialized in custom product development and FDA-compliant contract manufacturing, with a passion for cutting-edge formulations and innovative product selection. Now housed in a state-of-the-art 25,000 square foot facility in Tampa, Pure Solutions remains committed to its founding principles and is ready to expand its operations through growing organically by adding diversity to its in-house product lines and strategically through joint ventures, partnerships, acquisitions, exclusive manufacturing and distribution agreements, and mergers.
FAGI 的全資子公司 Bio Lab Naturals, Inc. 成立於2000年,通過其FDA註冊的全資子公司 Pure Solutions, Inc.,立足於使用最高質量的原料,生產具有最大可能功效的產品,並以公道的價格爲合作伙伴提供無與倫比的客戶服務。從成立的第一天起,公司就專門從事定製產品開發和符合FDA合規的合同製造,熱衷於開發最前沿的配方和創新產品選擇。現在,位於坦帕市 2.5萬平方英尺的尖端設施 Pure Solutions 依然致力於其創立原則,並準備通過通過增加自有產品線的多樣性和戰略性地通過合資企業,合作伙伴關係,收購,獨家制造和分銷協議以及併購來擴大其業務。
FAGI's other wholly owned subsidiary DynaMAXX International Ltd. is in the health and supplement space using the direct selling channel as its sales force with its main operations in the United States and Canada. DynaMAXX was founded in 2009 and has expanded globally since that time with its line of supplements. In addition to having a world class supplement product line, in October 2023 DynaMAXX launched the first ever cash pay medical referral network through its independent reps ("Members"); allowing its members to refer friends, family, other Members and customers to doctors who participate in the DynaMAXX Health Network. Initially, DynaMAXX Health Inc. is referring patients for EBOO/EBO2, PRP, Shockwave procedures to doctors in the network. DynaMAXX has a cost-effective way for individuals to participate in the ever-growing GIG economy by offering an aggressive compensation program to those that refer customers who purchase products, refer individuals to the DynaMAXX Health Network or to other individuals who want to start their own business. The company offers training and support to their distributors and has a strong focus on helping people achieve financial freedom through their business opportunity.
FAGI的另一個全資子公司DynaMAXX International Ltd. 在健康和補充領域使用直銷渠道作爲銷售力量,主要業務在美國和加拿大。 DynaMAXX成立於2009年,並自那時以來在全球範圍內擴張,擁有其補充劑產品線。除了擁有世界一流的補充劑產品線外,DynaMAXX在2023年10月通過其獨立代表(「成員」)首次推出了現金支付醫療轉診網絡;允許其成員將朋友、家人、其他成員和客戶推薦給參與DynaMAXX Health Network的醫生。最初,DynaMAXX Health Inc.將患者轉介到網絡中的醫生進行EBOO/EBO2、PRP和Shockwave等手術。DynaMAXX爲個人以具有成本效益的方式參與不斷增長的GIG經濟提供了一種積極的補償計劃,該計劃是向那些推薦購買產品的客戶、將個人推薦給DynaMAXX Health Network或者希望開始自己業務的其他個人提供的。該公司爲其分銷商提供培訓和支持,並將重點放在幫助人們通過其商機實現財務自由。
Fact Sheet:
事實表:
For media inquiries, please contact:
媒體垂詢,請聯繫:
Contact: Samantha Brainerd, Director of Sales and Marketing DYNAMAXX
Email: sbrainerd@dynamaxx.com
Phone: (949)-212-8863
聯繫人:Samantha Brainerd,銷售和市場總監DYNAMAXX
電子郵件:sbrainerd@dynamaxx.com
電話:(949)-212-8863
Full Alliance Group Inc. Investor Relations
全聯盟集團股東關係
Contact: Gabe Rodriguez, Erelations Group
Email: Erelationsgroup@gmail.com
Phone: (623) 261-9046
聯繫人:Gabe Rodriguez,電子關係組
電子郵件:Erelationsgroup@gmail.com
電話:(623) 261-9046
Forward-Looking Statements
前瞻性聲明
This shareholder update may contain forward-looking statements. Words and variations of words such as: "expect," "goals," "could," "plans," "believe," "continue," "may," "will," and similar expressions are intended to identify our forward-looking statements, including but not limited to our expectation for growth, benefits from brand-building, cost savings, and margins. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause our actual results to differ materially from those indicated in our forward-looking statements. Such factors include but are not limited to continued volatility of and sharp increase in costs/pricing actions, increased competition, ability to raise sufficient operating capital, risks from operating internationally, consumer weakness, weakness in economic conditions, and tax law changes.
此股東更新可能包含前瞻性聲明。諸如「預期」、「目標」、「可能」、「計劃」、「相信」、「繼續」、「可能」、「將」及類似表達意圖的語言和變體,旨在識別我們的前瞻性聲明,包括但不限於我們對增長、品牌建立、成本節約和邊際利潤的預期。這些前瞻性聲明受到許多超出我們控制範圍的風險和不確定性的影響,這可能導致我們的實際結果與我們的前瞻性聲明不符。這些因素包括但不限於成本/定價行動的持續波動和急劇上漲、增加的競爭、籌集足夠的運營資本、在國際範圍內運營的風險、消費者疲軟、經濟條件疲弱和稅法變更等。
SOURCE: Full Alliance Group, Inc.
來源:全聯盟集團股份有限公司